Humanigen Inc (fka HGENQ)

[rstar]

great article, wonderful first person experience:

While it is not clear which treatment group Marc was assigned to, within 24 hours after receiving the study drug, his symptoms dramatically improved and within about a week, he was discharged from the hospital and has since made a full recovery.

https://www.augustachronicle.com/ZZ/sponsored/20201019/recovered-covid-19-patient-urges-others-to-participate-in-clinical-trials

“To recover from this pandemic we will need therapeutics, combination approaches and vaccines,” said Cameron Durrant, MD, MBA, chief executive officer of Humanigen, the biopharmaceutical company developing lenzilumab. “When it comes to COVID-19, we believe that having a therapeutic, like lenzilumab, that may reduce the time to recovery and possibly send patients home earlier, is a near-term solution that has the potential to be a game-changer in the face of this pandemic.”